Rationale: Aortic stiffening commonly occurs in hypertension and further elevates systolic pressure. Hypertension is also associated with vascular inflammation and increased mechanical stretch. The interplay between inflammation, mechanical stretch, and aortic stiffening in hypertension remains undefined.
T he capacitance property of the aorta normally blunts blood pressure elevation during systole and maintains diastolic pressure and tissue perfusion during diastole. Loss of this Windkessel function of the proximal aorta causes an increase in systolic pressure, a decline in diastolic pressure, and an increase in pulse wave velocity. 1 The augmentation of systolic pressure caused by aortic stiffening increases the incidence of stroke, renal failure, and myocardial infarction. Aortic stiffening is associated with aging, insulin resistance, diabetes mellitus, atherosclerosis, and hypertriglyceridemia. [2] [3] [4] [5] Importantly, hypertension per se causes aortic stiffening, leading to progressive elevation of systolic pressure. Thus, aortic stiffening not only contributes to hypertension, but also portends cardiovascular morbidity and mortality. 6, 7 The precise mechanisms underlying aortic stiffening remain undefined. Clinical studies suggest that inflammation and arterial stiffness are related. [8] [9] [10] [11] Patients with inflammatory diseases such as lupus erythematosus, rheumatoid arthritis, and psoriasis have increased pulse wave velocity. [12] [13] [14] Data from our laboratory and others have shown that T-cells and T-cell-derived cytokines are important in the development of hypertension. 15, 16 We previously found that recombination activating gene-1-deficient (RAG-1 −/− ) mice developed blunted hypertension in response to angiotensin II, deoxycorticosterone acetate (DOCA)-salt challenge, and norepinephrine. 17 The RAG-1 gene encodes a gene responsible for recombining the variable regions of the T-cell receptor and immunoglobulins, and in its absence, the mice fail to develop either B-cells or T-cells. Adoptive transfer of T-cells restores hypertension in RAG-1 −/− mice, indicating a critical role of these cells. Recently, deletion of the RAG-1 gene in Dahl salt-sensitive rats has been shown to lower blood pressure and to reduce renal injury on salt feeding. 18 Other studies have shown that T-cell-derived cytokines also contribute to hypertension, likely by promoting vascular dysfunction and renal injury. 16, 19, 20 One such cytokine is interleukin 17a (IL-17a), which is produced by a subset of proinflammatory CD4
+ T helper cells referred to as T H 17 cells. Mice lacking IL-17a have blunted hypertension and reduced aortic production of reactive oxygen species after angiotensin II infusion. Recent studies also showed that the administration of IL-17a to mice caused hypertension and reduced endothelium-dependent vasodilatation, at least in part by activating Rho-kinase. 21 IL-17a also promotes collagen deposition and contributes to fibrosis in other tissues and conditions. [22] [23] [24] In the present study, we sought to examine mechanisms responsible for aortic stiffening in hypertension. In particular, we examined the role of adaptive immunity mediated by T-cells and their cytokines and the direct effects of mechanical stimulation by blood pressure lowering and by exposing aortic fibroblasts to hypertensive levels of stretch. We identified a novel pathway that promotes striking aortic adventitial collagen deposition and vascular stiffening. , and IL-17a −/− mice were studied at 3 months of age. Hypertension was induced by the infusion of angiotensin II (490 ng-/kg per minute) via osmotic minipumps for 2 weeks unless otherwise indicated. For the measurement of blood pressure, mice were implanted with telemetry units, and 10 days later, osmotic minipumps were placed. Blood pressure was recorded for 10 minutes every hour from 3 days before osmotic minipump implantation until the end of angiotensin II infusion at day 14. For studies of vascular stiffness, the descending thoracic aorta was mounted on cannulas at the in situ length in calcium-free buffer. Intraluminal pressure was increased in a step-wise fashion, whereas video microscopy was used to follow outer and inner diameter. Diameters were recorded with every increment of 25 mm Hg from 0 to 200 mm Hg. Stress-strain relationships were calculated as described by Baumbach et al. 25 In some experiments, RAG-1 −/− mice underwent adoptive transfer of T-cells or their subsets, as described previously. 26 The Institutional Animal Care and Use Committee approved all experimental protocols.
Methods

Animals
Flow Cytometry
Single-cell suspensions were prepared from the aortas as previously described. 27 Leukocytes were further isolated using a Percoll gradient. The antibodies used were FITC anti-CD45, PerCP anti-CD45, PE anti-CD3e, FITC anti-CD3e, APC anti-CD3, APC anti-CD4, PerCP anti-CD8a, and PE-Cy7 anti-CD8a.
Measurement of Aortic Collagen and Elastin
Aortic collagen was visualized by Masson trichrome staining and quantified by the measurement of tissue hydroxyproline as described previously. 28 Elastin was visualized by Verhoeff Van Gieson staining and quantified as previously described, 29, 30 with minor modifications as outlined in the Online Data Supplement.
Cell Culture
Low-passage mouse aortic fibroblasts were studied at 90% confluence. The media was changed from 5% to 0.5% FBS for 24 hours before experiments. Cells were exposed to either cyclic stretch or to IL-17a (100 ng/mL) for 36 hours.
Real-Time PCR and Western Blotting
RNA was extracted from the aortas or cultured fibroblasts using the Qiagen RNeasy minikit. PCR array was performed to screen for matrix and inflammatory genes, and real-time PCR was used to examine selected fibrotic genes. Western blotting was performed using specific rabbit antimouse monoclonal primary antibodies and goat antirabbit polyclonal secondary antibodies. Western blots were quantified by densitometry.
Statistical Analysis
Data in the article are expressed as mean±SEM. Comparisons of blood pressure over time were made using 1-way ANOVA for repeated measures, followed by a Student-Newman-Keuls post hoc test when significance was indicated. Compliance curves and stressstrain curves were also compared using ANOVA for repeated measures. To compare the effect of angiotensin II on parameters other than blood pressure, 2-way ANOVA was used, as indicated. The effects of adoptive transfer of pan T-cells or antihypertensive treatment on collagen deposition or aortic inflammation were compared using 1-way ANOVA. P values are reported in the figures.
A detailed description of the materials and methods can be found in the Online Data Supplement.
Results
Effect of Angiotensin II-Induced Hypertension on Aortic Collagen and Elastin Content: Role of T-Cells
Two matrix components that predominantly modulate tissue compliance are collagen and elastin. We performed initial studies to determine how hypertension affects these and to understand the role of T-cells in this response. Using Masson trichrome staining, we observed that collagen is predominantly localized to the adventitia of the aorta of sham-infused mice. During angiotensin II infusion, a striking accumulation of collagen in the aortic adventitia occurred. The thickness of this adventitial collagen deposition was often equivalent to the media ( Figure 1A and 1B) . By planimetry, adventitial collagen area was increased from 3.8×10 4 to 13.6×10 4 μm 2 by angiotensin II treatment. To quantify aortic collagen directly, we measured hydroxyproline content, which was 19±7 ng/μg of total protein in WT mice and was doubled by chronic angiotensin II infusion ( Figure 1C) . Thus, by both histochemical staining and biochemical analysis, we found that angiotensin II-induced hypertension is associated with a 2-to 3-fold increase in aortic collagen content, predominantly localized to the adventitia. We and others have established a role of T-cells in hypertension. 15, 16 Moreover, the T-cell-derived cytokine IL-17 contributes to hypertension and has been shown to promote collagen deposition in experimental scleroderma. 17 We therefore examined the role of T-cells in aortic stiffening. As in previous studies, we found that the hypertensive response to angiotensin II is blunted in RAG-1 −/− mice (Online Figure IA and IB). In addition, the increase in aortic collagen content caused by angiotensin II, as detected by either Masson trichrome staining or by hydroxyproline assay, was blunted in RAG-1 −/− mice ( Figure 1A-1C Figure 1D ). When normalized to total protein, relative elastin levels were decreased by angiotensin II in both mouse strains (Online Figure IF) , but this could be attributed to the striking increase in total aortic protein associated with angiotensin II-induced aortic hypertrophy (Online Figure IG) .
Angiotensin II-Induced Hypertension Causes Dramatic Changes in the Expression of Aortic Matrix Genes
In addition to collagen and elastin, numerous other matrix proteins can influence vascular stiffness. We therefore performed a PCR array to characterize the expression of 84 aortic matrix genes related to fibrosis and remodeling. In response to angiotensin II infusion, 17 out of 84 genes were significantly upregulated, whereas no genes were downregulated (Online Table  I ). Among these, collagen 1a1 and matrix metalloproteinase (MMP)-2 were upregulated by >8-fold and collagen 3a1 by 7-fold. MMP-11, thrombospondin-1, thrombospondin-2, and secreted acidic cysteine-rich glycoprotein were upregulated by 4-to 5-fold. We also found >3-fold upregulation for collagen 5a1 and MMP-14. Surprisingly, the potent profibrotic cytokine, transforming growth factor (TGF)-β1, was not altered in angiotensin II-induced hypertension.
Hypertension Reduces Aortic Compliance: Role of T-Cells
Additional studies were performed to measure the compliance of isolated segments of the descending thoracic aorta. Chronic angiotensin II infusion caused marked stiffening of the thoracic aorta in WT mice as evidenced by a downward shift of the compliance curve ( Figure 2A ) and a leftward shift of the stress-strain relationship ( Figure 2B ). In contrast, in RAG-1 −/− mice, chronic angiotensin II infusion had essentially no effect on aortic stiffness. Adoptive transfer of T-cells to RAG-1 −/− mice restored the increase in aortic stiffening caused by angiotensin II (Figure 2C and 2D) . Analysis of changes in vascular inner and outer diameter showed that these increased in parallel in vessels from sham-treated mice as intraluminal pressure was increased. In contrast, after angiotensin II infusion, the increase in outer diameter was constrained in the aortas from WT mice, but not in the aortas from RAG-1 −/− mice ( Figure 2E and 2F) .
To determine the relative contribution of T-cell subtypes, we examined the effect of angiotensin II infusion in CD4 −/− and CD8 −/− mice. The increase in collagen caused by angiotensin II was blunted in mice lacking either T-cell subtype, but was most striking in mice lacking CD8 + T-cells as evidenced by both Masson trichrome staining and hydroxyproline assay (Online Figure IIIA-IIIC) . In addition, CD4 −/− and CD8 −/− mice were both partially protected against the development of aortic stiffening caused by angiotensin II (Online Figure IIID-IIIG) . In additional studies, we performed adoptive transfer of CD4 + T-cells or CD8 + T-cells to RAG-1 −/− mice and then infused angiotensin II 3 weeks later. Neither cell type alone increased aortic stiffness or collagen content significantly (Online Figure IV) . These data indicate that both cell types are required and likely interact to mediate hypertension-related aortic stiffening.
We have previously shown that mice lacking IL-17a are protected against the development of hypertension, aortic inflammation, and angiotensin II-induced vascular oxidative stress. 16 In the present study, we found that IL-17a −/− mice are also protected against aortic collagen deposition ( Figure 3A -3C) and aortic stiffening ( Figure 3D and 3E) in response to chronic angiotensin II infusion.
We have previously shown that T-cells play a role in the models of hypertension other than angiotensin II infusion, including DOCA-salt hypertension and norepinephrine-induced hypertension. 15, 17 To determine if the reduced adventitial collagen deposition and aortic stiffening in RAG-1 −/− mice are specific to angiotensin II, we also studied DOCA-salt-induced hypertension, which is characterized by low levels of circulating angiotensin II. As shown in Online Figure V , although WT mice developed marked collagen deposition and aortic stiffening in response to DOCA-salt challenge, RAG-1 −/− mice were protected from these changes. These data suggest that T-cells contribute to aortic stiffening in forms of hypertension other than that caused by angiotensin II.
Aortic Stiffening Is Dependent on Blood Pressure Elevation
In clinical studies, aortic stiffening is commonly associated with hypertension; however, the causal relationship remains February 14, 2014 unclear. To address the possible role of pressure elevation in the genesis of aortic stiffening, we normalized the blood pressure in angiotensin II-infused mice by adding hydralazine (320 mg/L) and hydrochlorothiazide (60 mg/L) to the drinking water. As shown in Figure 4A and 4B, concurrent hydralazine and hydrochlorothiazide treatment completely prevented the elevation of blood pressure. This treatment also protected against adventitial collagen deposition ( Figure 4C-4E ). More importantly, the shifts in compliance and stress-strain curves were prevented by this treatment regimen ( Figure 4F and 4G) . Interestingly, we found that hydralazine and hydrochlorothiazide also abrogated T-cell infiltration and inflammation in aortas of angiotensin II-infused mice ( Figure 4H-4L) . Collectively, these data suggest that aortic stiffening and vascular inflammation are, at least in part, due to the mechanical effects of hypertension.
To determine whether normalization of blood pressure in established hypertension could reverse collagen deposition and aortic stiffening, hydralazine and hydrochlorothiazide treatment was administered from day 15 to day 28 during a 4-week angiotensin II infusion. Although this successfully normalized blood pressure during the last 2 weeks of angiotensin II infusion, it failed to reverse adventitial collagen deposition and aortic stiffening (Online Figure VI) . These data suggest that hypertension might cause irreversible large-vessel fibrosis and remodeling.
Aortic Fibroblasts Express Collagen in Response to IL-17a and Hypertensive Mechanical Stretch
The above experiments suggest that both inflammation and mechanical forces contribute to aortic stiffening. To differentiate between the direct effect of mechanical stretch and the inflammatory cytokine IL-17a, we performed additional studies using cell culture. Because we found that aortic collagen deposition in hypertension occurs largely in the adventitia, we studied aortic fibroblasts, which represent the predominant cell type of the adventitia. We focused these studies on collagen subtypes identified in the real-time PCR array. Fibroblasts were exposed to either 5% or 10% stretch, mimicking the levels of mechanical stretch observed in the setting of normal and elevated blood pressures, or were exposed to IL-17a (100 ng/mL) for 36 hours. We found that although IL-17a had no effect on the mRNA expression of collagen 1a1, 10% mechanical stretch doubled expression of this subtype beyond Mice were treated with hydralazine and hydrochlorothiazide (320 and 60 mg/L, respectively, in the drinking water) concurrently with angiotensin II infusion. HCTZ indicates hydrochlorothiazide; and Hyd, hydralazine. A and B, Telemetry recording of blood pressures. D indicates day; and N, night. The effects of blood pressure normalization on collagen depostion (C-E), aortic stiffening (F and G), and aortic inflammatory cell infiltration (H-L) are shown. Scale bar indicates 100 μm. Ang II indicates angiotensin II. Data for blood pressure and aortic stiffness were analyzed using 1-way ANOVA with repeated measurements (n=8). Collagen deposition and flow cytometry were analyzed using 1-way ANOVA (n=8).
that observed with 5% stretch (Table) . Collagen 3a1 was increased by >4-fold by IL-17a and by >3-fold in response to 10% stretch. Collagen 5a1 mRNA expression was increased ≈2-fold by IL-17a and by 10% stretch, but was not further increased by the combination of this cytokine and stretch. The addition of angiotensin II had minimal effect on these responses except for collagen 3a1, where it doubled the effect of 10% stretch. These experiments show that the hypertensive milieu, which includes increased vascular stretch, inflammatory cytokines such as IL-17a and angiotensin II, interact to modulate aortic fibroblast collagen production.
Activation of p38 Mitogen-Activated Protein Kinase Is Required for Collagen Expression and Aortic Collagen Deposition Induced by Stretch and Inflammation In Vitro and In Vivo
p38 Mitogen-activated protein kinase (MAPK) has been implicated in the induction of collagen expression and fibrosis in different hypertensive models. [31] [32] [33] [34] Interestingly, both 10% stretch and IL-17a at 100 ng/mL induced p38 MAPK phosphorylation in aortic fibroblasts ( Figure 5A-5C) . Moreover, the inhibition of p38 MAPK with SB203580 prevented the increase in mRNA for collagens 1a1, 3a1, and 5a1 caused by stretch ( Figure 5D-5F ). SB203580 also inhibited IL-17a-induced expression of collagen 3a1 but not collagen 5a1 ( Figure 5G-5I) . We also found that angiotensin II-induced hypertension increased p38 MAPK phosphorylation in thoracic aortas, and that this was prevented by the normalization of blood pressure ( Figure 6A-6C) . To gain insight into the role of p38 MAPK in vivo, we treated mice with SB203580 (10 mg/kg per day, intraperitoneally) concurrently with angiotensin II. SB203580 reduced the hypertension caused by angiotensin II (Figure 6D and 6E). More importantly, SB203580 prevented collagen deposition ( Figure 6F-6H) as well as the shift in aortic compliance and stress-strain relationships caused by angiotensin II (Figure 6I and 6J ). These data show that p38 MAPK is responsive to stretch and inflammation and thus plays a central role in mediating collagen expression in cultured fibroblasts and in inducing aortic stiffness in vivo.
Discussion
In the present study, we identified novel mechanisms of aortic stiffening associated with hypertension as delineated in the scheme shown in Figure 7 . Our data indicate that the elevation Figure 5 . Effect of cyclic stretch and interleukin (IL)-17a on aortic fibroblasts and the role of p38 MAPK. Mouse aortic fibrobasts were exposed to various degrees of cyclic stretch or the T-cell cytokine IL-17a (100 ng/mL) in culture for 36 h. A to C, Both hypertensive mechanical stretch and IL-17a activated p38 MAPK in cultured mouse aortic fibroblasts. D to F, The effects of p38 inhibitor SB203580 (10 ng/mL) on mechanical stretch-induced expression of collagen subtypes in fibroblasts. G to I, The effects of p38 inhibition on IL-17a-induced collagen expression. Data are analyzed using 1-way ANOVA, n=3 to 6. Primary mouse aortic fibroblasts were exposed to 5% or 10% cyclic stretch or to IL-17a (100 ng/mL) in the presence or absence of angiotensin II (100 nmol/L) for 36 h. Relative quantity of mRNA was calculated based on the ΔΔCt value normalized to control. Data are expressed as mean±SE. The effects of IL-17a and mechanical stretch are analyzed with 1-way ANOVA, whereas the effects of angiotensin II by 2-way ANOVA (n=3-6). NA indicates not assessed. *P<0.05. **P<0.01 vs control. #P<0.05 vs angiotensin II. February 14, 2014
of blood pressure and the attendent increase in vascular stretch lead to an inflammatory process characterized by infiltration of T-cells and activation of p38 MAPK. These events lead to a striking deposition of collagen in the aortic adventitia, with scattered amounts of collagen in the media. This is associated with a marked alteration in aortic complaince, characterized by a leftward shift in the stress-strain relationship and a downward relationship between aortic distending pressure and diameter. In vivo, this increase in aortic stiffness leads to a loss of Windkessel or capacitance function of the aorta, increasing systolic pressure and promoting hypertension-related end-organ damage. Interestingly, we found that T-cells and in particular the T-cell-derived cytokine IL-17a contribute to aortic stiffening. We have previously shown that mice lacking IL-17a are protected against hypertension. 16 More recently, IL-17 has been shown to increase Rho-kinase-mediated phosphorylation of endothelial nitric oxide synthase, to promote endothelial dysfunction, and to elevate blood pressure when administered parenterally. 21 In keeping with a role of inflammation in collagen deposition, we found that RAG-1 −/− and IL-17a −/− mice are protected against aortic stiffening and collagen depostion during angiotensin II infusion and that the adoptive transfer of T-cells to RAG-1 −/− mice restores these abnormalities. We cannot exclude a role of cytokines other than IL-17a. As an example, TNFα often acts synergistically with IL-17 to promote inflammatory responses. Recent studies showed that etanercept, a TNFα antagoinist, reduces pulse wave velocity and aortic stiffness in patients with rheumatoid arthritis. 35, 36 We also found that mice treated with etanercept and mice lacking IL-17a are protected against these vascular alterations. 15 Thus, it is possible that this and other cytokines act in concert with IL-17 to promote aortic stiffening.
It is likely that both CD4 + and CD8 + T-cells contribute to aortic stiffening, because mice lacking either one alone had + T-cells produce substantial amounts of cytokines and contribute to the inflammatory millieu. 37, 38 In preliminary studies, we found that angiotensin II infusion induces IL-17a production in several T-cell subtypes in vivo.
Our data also indicate that the mechanical effect of increased blood pressure also contributes to aortic stiffening. Notably, hydralazine and hydrochlorothiazide, which were used to prevent hypertension, also prevented collagen deposition and increase in aortic stiffness caused by chronic angiotensin II infusion. These data do not separate mechanical effects from inflammation, because blood pressure lowering also prevented aortic leukocyte iniltration. In keeping with this finding, there are numerous mechanisms by which mechanical stretch could affect vascular inflammation. For example, increased cyclic strain, similar to that observed in hypertension, activates NADPH oxidase and NF-κB, increases the expression of intracellular adhesion molecule-1, and enhances adhesion of monocytes to the endothelium. 39, 40 Substantial research has focused on the role of TGF-β in tissue fibrosis and collagen deposition. In several preliminary studies, we found that mRNA for TGF-β1 was increased neither in the aortas from angiotensin II-treated mice nor in cultured fibroblasts exposed to stretch. This does not exclude the possibility that TGF-β activity is increased at a post-translational level in response to hypertension. Latent TGF-β is processed to its active form by components of the inflammatory milieu, including MMPs, reactive oxygen species, thrombospondin-1, and integrins. 41, 42 Related to this, our array analysis of the genes affected by hypertension provides insight. This analysis showed that hypertension led to a 9-fold increase in MMP-2 and a 5-fold increase in thrombospondin-1. These could contribute to the post-translational activation of latent TGF-β in the absence of changes in its expression.
In an effort to separate the direct effects of stretch and inflammation, we exposed cultured murine aortic fibrobasts to either cyclic stetch or IL-17a. We selected fibroblasts because these represent the predominant cell in the adventital region where collagen deposition occurs. Our data indicate that both these stimuli induce mRNA of various collagen subtypes, all of which could contribute to aortic stiffening. Our data also indicate that p38 MAPK likely plays an important role in collagen expression both in cultured fibroblasts and in vivo. Several studies showed that the inhibition of p38 blocks the profibrotic effects of mechanical stretch both in vitro and in vivo. Park et al 32 showed that the inhibition of p38 MAPK reduces cardiac and renal fibrosis in double transgenic rats harboring the human renin and angiotensinogen genes. Similarly, p38 inhibition decreases cyclic stretch-induced collagen expression in isolated smooth muscle cells from Wistar-Kyoto and spontaneously hypertensive rats. 34 Of note, p38 MAPK has been shown to bypass TGF-β signaling by the transactivation of Smad-2/3 in a mouse model of Marfan Syndrome, and systemic inhibition of p38 blocks these effects. In addition, increased activation of p38 MAPK due to loss of MAPK phosphatase-1 activity induces the expression of microRNA-21, 43 a critical regulator of TGF-β signaling involved in renal and myocaridal fibrosis. [44] [45] [46] microRNA-21 inhibits Smad-7 and augments TGF-β signaling, enhancing its profibrotic effects. 47 Interestingly, microRNA-21 also contributes to renal fibrosis by regulating MMP-9/tissue inhibitor of metalloproteinase 1. Thus, p38 MAPK plays a pivital role in the interaction between vascular inflammation and mechanical stretch.
It would be desirable to differentiate the causal relationship between aortic stiffening and hypertension in vivo. Recent data from the Framingham study indicate that increases in pulse wave velocity precede the development of overt hypertension in the general population. 48 Our study does not refute this, but suggests that once hypertension is initiated, aortic stiffening is markedly exagerated. In keeping with this, in mice subjected to transverse aortic constriction, adventitial collagen deposition is observed proximal to the constriction where pressures are elevated, but not distal to the constriction where pressures are normal. 49 Likewise, a recent study suggests that mild hypertension in children predisposes to increasesd pulse wave velocity in adulthood. 50 No matter the cause, stiffening of the proximal aorta leads to loss of the Windkessel effect, further elevating systolic blood pressure. Therefore, in the long run, aortic stiffening and hypertension likely promote one another, ultimately leading to progressive elevations in systolic blood pressure.
In the present study, the absolute amount of elastin present in the aorta was not affected by angiotensin II infusion, whereas the relative amount of elastin, expressed as a percent of total protein, was reduced by ≈50%. This relative loss of elastin might also contribute to the reduced aortic compliance observed in angiotensin II-induced hypertension. Loss of aortic elastin leads to aortic stiffening and hypertension in mice that are haploinsufficient for the elastin gene. 51 It is also possible that although total elastin is not changed, elastin damage might occur in the setting of angiotensin II-induced hypertension. Of note, MMP-3, which was increased by 2.5-fold by angiotensin II infusion in our gene array analysis, has elastase activity and could contribute to elastin fragmentation in hypertension.
The striking deposition of collagen in the adventitial layer might not only promote vascular stiffness, but also increase the compression of vascular smooth muscle cells during systole. Our in vitro studies showed that when intraluminal pressure is increased in a normal aorta, there is relatively equal expansion of both the lumen and the outer vascular media, thus preserving medial thickness. In contrast, increasing intraluminal pressure in the aortas from angiotensin II-treated mice led to an increase in the lumen that was substantially greater than that of the outer media, leading to compression of the media. This could lead to a condition in which vascular smooth muscle cells undergo cyclic compression during each cardiac cycle. The impact of this on vascular smooth muscle function remains to be defined.
In summary, this study provides new insight into mechansims of aortic stiffening in hypertension as depicted in February 14, 2014 Figure 7 . An important component of this process is a striking deposition of collagen in the adventitia. Our data indicate that aortic stiffening is mediated by both mechanical factors associated with elevated pressure and by T-cells and their release of inflammatory cytokines. p38 MAPK likely plays an important signaling role in response to these stimuli. Adventitial collagen deposition and aortic stiffening can be considered a form of end-organ damage in hypertension, and these further elevate systolic pressure, leading to disease progression.
